Pharma & life sciences by the numbers

$25.5M

Pharma and life sciences companies spent an average of $25.5 million on litigation in 2020.

58%

of pharma and life sciences companies neglected to pursue judgments in the last year due to the cost of doing so.

$32.7M

The average value of their unenforced judgments was $32.7 million.

We help pharma & life sciences companies maximize returns on legal assets

Corporations from startups to the Fortune 500 use Burford’s solutions to:

  • Remove cost, create budget certainty and reduce risk around complex commercial matters
  • Generate immediate liquidity from pending claims, judgments and awards
  • Leverage high value claims to offset cost of defense matters

Precedent transactions

Why Burford?

Band 1

ranked by Chambers in the US and UK

70%

of clients return to do business again

$4.5B

current investment portfolio

Hundreds of corporations have worked with Burford's award-winning team.

To learn more about working with Burford, contact our team.

Read Joshua Harris's Profile
Joshua Harris

Joshua Harris

Senior Vice President

Read Eric Carlson's Profile
Eric Carlson

Eric Carlson

Director